EDUARDO
DÍAZ-RUBIO GARCÍA
Forscher bis um 2020
Martin Luther University Halle-Wittenberg
Halle, AlemaniaPublikationen in Zusammenarbeit mit Forschern von Martin Luther University Halle-Wittenberg (13)
2023
2019
-
Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer
JAMA network open, Vol. 2, Núm. 9, pp. e1911750
2015
-
Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: Findings from the analysis and research in cancers of the digestive system database
Journal of Clinical Oncology, Vol. 33, Núm. 1, pp. 22-28
2011
2009
2008
-
Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: A pooled analysis of randomized trials
Journal of Clinical Oncology, Vol. 26, Núm. 36, pp. 5910-5917
-
The diagnosis and management of rectal cancer: Expert discussion and recommendations derived from the 9th world congress on gastrointestinal cancer, Barcelona, 2007
Annals of Oncology
2007
2006
2005
-
Introduction
Oncology
-
The future development of bevacizumab in colorectal cancer
Oncology, Vol. 69, Núm. SUPPL. 3, pp. 34-45
2002
-
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)
European Journal of Cancer, Vol. 38, Núm. 11, pp. 1429-1436
1998
-
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG
Tumori, Vol. 84, Núm. 3, pp. 335-347